104 related articles for article (PubMed ID: 2332039)
1. Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia.
Haus O; Noworolska A; Laskowski M; Kuliszkiewicz-Janus M; Kozłowska J; Harłozińska-Szmyrka A; Jagielski J; Kotlarek-Haus S
Exp Mol Pathol; 1990 Apr; 52(2):235-42. PubMed ID: 2332039
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics of chronic myelogenous leukemia (CML) correlated to the histopathology of bone marrow biopsies.
Werner M; Kaloutsi V; Buhr T; Delventhal S; Vykoupil KF; Georgii A
Ann Hematol; 1991 Oct; 63(4):201-5. PubMed ID: 1932298
[TBL] [Abstract][Full Text] [Related]
3. [Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].
Maeda T; Ashie T; Kikuiri K; Ishiyama N; Takakura M
Rinsho Ketsueki; 1989 Jul; 30(7):1032-6. PubMed ID: 2810787
[TBL] [Abstract][Full Text] [Related]
4. Extramedullary pleural blast crisis in chronic myelogenous leukemia: cytogenetic and molecular study.
Sacchi S; Temperani P; Selleri L; Zucchini P; Morselli S; Vecchi A; Longo R; Torelli G; Emilia G; Torelli U
Acta Haematol; 1990; 83(4):198-202. PubMed ID: 2115717
[TBL] [Abstract][Full Text] [Related]
5. [Chronic myeloid leukemia. Karyotype changes].
Rojas-Atencio A; Pineda-Del Villar L; Avila-León E; González-Ferrer S; Prieto-Carrasquero M; Soto M; González R
Invest Clin; 1996 Sep; 37(3):167-75. PubMed ID: 8983354
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
[TBL] [Abstract][Full Text] [Related]
8. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.
Wang Y; Hopwood VL; Hu P; Lennon A; Osterberger J; Glassman A
Cancer Genet Cytogenet; 2004 Aug; 153(1):53-6. PubMed ID: 15325094
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
Wells SJ; Phillips CN; Winton EF; Farhi DC
Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic follow-up after bone marrow transplantation for Philadelphia-positive chronic myeloid leukemia.
Sessarego M; Frassoni F; Defferrari R; Bacigalupo A; Miceli S; Mareni C; Ajmar F
Cancer Genet Cytogenet; 1989 Oct; 42(2):253-61. PubMed ID: 2790760
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).
Slovak ML; Kopecky KJ; Wolman SR; Henslee-Downey JP; Appelbaum FR; Forman SJ; Blume KG
Leuk Res; 1995 Jun; 19(6):381-8. PubMed ID: 7596150
[TBL] [Abstract][Full Text] [Related]
12. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
14. [Complex cytogenetic aberrations in a patient with chronic myeloid leukemia: a case report].
Luk'ianova AS; Pien'kovs'ka-Hrelia B; Masliak ZV
Tsitol Genet; 2009; 43(3):48-54. PubMed ID: 19938637
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic investigation in chronic myeloid leukemia: study from an Indian population.
Chavan D; Ahmad F; Iyer P; Dalvi R; Kulkarni A; Mandava S; Das BR
Asian Pac J Cancer Prev; 2006; 7(3):423-6. PubMed ID: 17059336
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
[TBL] [Abstract][Full Text] [Related]
17. Extramedullary blastic transformation in a child with adult chronic myelocytic leukemia.
Van Dijken PJ; Niazi M; al-Asiri RH
Cancer Genet Cytogenet; 1994 Sep; 76(2):151-3. PubMed ID: 7923067
[TBL] [Abstract][Full Text] [Related]
18. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic implications of secondary chromosomal aberrations in Philadelphia chromosome-positive chronic myeloid leukemia patients after imatinib mesylate treatment].
Zhang Y; Jiang Q; Qiu JY; Chen SS; Jiang B; Huang XJ
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):648-50. PubMed ID: 17967235
[TBL] [Abstract][Full Text] [Related]
20. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
